| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $52.1M | +20.4% |
| Cost of Revenue | $47.4M | +27.0% |
| R&D Expense | $52K | -38.8% |
| SG&A Expense | $6.2M | +13.9% |
| Operating Income | -$6.4M | -28.4% |
| Pre-tax Income | -$6.4M | +56.2% |
| Income Tax | $24K | -56.4% |
| Net Income | -$6.5M | +56.2% |
| EPS (Basic) | -$0.26 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -25.3% |
| Accounts Receivable | $6.2M | +3.7% |
| Current Assets | $7.6M | -11.9% |
| Total Assets | $21.2M | -12.1% |
| Current Liabilities | $6.1M | -21.4% |
| Total Liabilities | $6.1M | -22.2% |
| Stockholders' Equity | $15.1M | -7.3% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$212K | -109.6% |
| Capital Expenditures | $154K | -51.6% |
| Investing Cash Flow | -$154K | +88.4% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | -$366K | -119.3% |
| +61.8% |